Clinical Trial Update: Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer [EARLY_Phase 1]

View source ↗

Summary

The clinical trial update reports that the EARLY_PHASE1 study using contrast-enhanced ultrasound to identify sentinel nodes in Esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Esophagus | EARLY_Phase 1 | Status: COMPLETED